发明名称 ARYL HYDROCARBON RECEPTOR (AhR) MODIFIERS AS NOVEL CANCER THERAPEUTICS
摘要 Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
申请公布号 US2016175278(A1) 申请公布日期 2016.06.23
申请号 US201615059911 申请日期 2016.03.03
申请人 Trustees of Boston University ;Northeastern University ;Boston Medical Center Corporation 发明人 SHERR David H.;POLLASTRI Michael;SCHLEZINGER Jennifer;HAIGH MOLINA Sarah;SCHAUS Scott;GIGUERE Joshua Robert
分类号 A61K31/352;A61K45/06 主分类号 A61K31/352
代理机构 代理人
主权项 1. A composition comprising wherein: X′ is alkyl, aryl or a substituted amino; n is 1; R2 is a substituted heteroaryl, R3, R4, R5 and R6 are H, and pharmaceutically acceptable salts thereof.
地址 Boston MA US